Name of organisation
1) Department/Research groupDepartment of Chronic Diseases, Pharmacoepidemiologic Research Group,
2) Organisation/affiliationNorwegian Institute of Public Health
Short Name in the inventoryNIPH
Administrative Contact
Title Dr
Last name Furu
First name Kari
Address line 1P.O.Box 222 Skøyen
Address line 2
Address line 3
CityOSLO
PostcodeNO-0213
CountryNorway
Phone number (incl. country code)4721078185
Alternative phone number4795221824
Fax number (incl. country code)
Scientific Contact
Title Dr
Last name Furu
First name Kari
Address line 1P.O.Box 222 Skøyen
Address line 2
Address line 3
CityOSLO
PostcodeNO-0213
CountryNorway
Phone number (incl. country code)4721078185
Alternative phone number4795221824
Fax number (incl. country code)
Alternative Scientific Contact
Title Dr
Last name Karlstad
First name Øystein
Address line 1P.O.Box 222 Skøyen
Address line 2
Address line 3
CityOSLO
PostcodeNO-0213
CountryNorway
Phone number (incl. country code)
Alternative phone number
Fax number (incl. country code)
2. Description
The Pharmacoepi Research Unit at the Dept Chronic Diseases, at the Norwegian Institute of Public Health (NIPH) is the largest pharmacoepi research entity in Norway with 8 fulltime research scientists. We have long experience in using Norwegian and Nordic high-quality population-based health registers in our research. NIPH run the Norwegian Prescription Database (NorPD), a nationwide prescription database and also has 10 other nationwide health registers in-house, i.e. the Norwegian Medical Birth Registry, Cause of death registry and large population-based health surveys.
3. Category
Government based
Public research institute
4. Available resources
In houseVia Contacts/Network
Epidemiologist/Pharmacoepidemiologist
Yes
No
Statistician
Yes
No
Clinician
Yes
Yes
Clinical Pharmacologist
Yes
No
Pharmacist
Yes
No
Geneticist/Pharmacogeneticist
Yes
No
IT specialist
Yes
No
Ethics expertise
No
Yes
Legal expertise
Yes
No
Regulatory expertise
No
Yes
5. Therapeutic/disease areas of research in drug safety/risk-benefit performed in the past 5 years
Cardiovascular diseases
Congenital Malformations
Disorders of the central nervous system
Immunological products and vaccines
Malignant disease
Osteoporosis
Pregnancy
Psychiatry
Respiratory diseases
Skin disorders
6. Design of drug safety/risk-benefit studies published in the past 5 years
Cohort Study
Drug Utilisation
Meta-Analysis
7. Experience in collecting data directly from individual patients/respondents
None
8. Access to data collection resources
Capacity to conduct face-to-face interviews
No
Electronic data capture systems
No
Interactive voice response systems
No
Call centre
No
9. Experience in secondary research and meta-analysis
No
10. Work with existing data resources in the past 3 years
Name of data resourceNo. of studies
NorPD30
Danish Medical Registries6
The Swedish prescribed drug register8
Icelandic National Registries5
Drugs and Pregnancy Finland5
11. Registries established by centre
Drug RegistryNorPD, all drug classes, nationwide dispensed drug database
Disease RegistryNorwegian Heart diseases
Other Norwegian Medical Birth registry, Cause of Death Registry
12. Experience in collaboration in a study team
Principal Investigator
Collaborating Investigator
13. Current involvement in research networks
Networks registered with ENCePP
EUROCAT
EuroDURG
Other networks:
Network nameNationalInternationalLink to webpage